ALISON ARMOUR: Open Payments
NPI 1215390182 · WASILLA, AK. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$950 in 29 payments from 12 companies in 2025. Trend: 2023 $1,199 · 2024 $1,204 · 2025 $950
Food & beverage: $950
| Company | Payments | Amount |
|---|---|---|
| TG Therapeutics, Inc. | 7 | $274 |
| ABBVIE INC. | 8 | $248 |
| EMD Serono, Inc. | 2 | $167 |
| Biogen, Inc. | 3 | $66 |
| Neurocrine BioSciences, Inc. | 2 | $36 |
| Eisai Inc. | 1 | $31 |
| Neurelis, Inc. | 1 | $26 |
| TMS NeuroHealth Centers Inc. | 1 | $25 |
| CSL Behring | 1 | $23 |
| GENZYME CORPORATION | 1 | $23 |
Products named: BRIUMVI, UBRELVY, LEQEMBI, BOTOX, INGREZZA, VALTOCO, TMS NeuroHealth Centers Inc., Hizentra.
Industry payments across AK — which companies pay providers there.
